MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/jcm14248768

Медицинская библиотека · Journal of clinical medicine · 2025

Four-Year Outcomes of aXess Arteriovenous Conduit in Hemodialysis Patients: Insights from Two Case Reports of the aXess FIH Study.

Vitkauskaitė Monika, Rimševičius Laurynas, Girčius Rokas, Cox Martijn A J, Miglinas Marius

Клинический случайСтатьяПеревод в очереди

Аннотация

Background/

Objectives

Arteriovenous grafts (AVGs) are critical for hemodialysis access in patients with inadequate native vasculature. The Xeltis aXess graft, a novel bioresorbable vascular access conduit, promotes endogenous tissue restoration. While early outcomes have been promising, longer-term data remain limited. This report presents the longest reported, four-year follow-up on two of the first implanted aXess devices. Case Summaries: Case 1: A 64-year-old woman underwent aXess graft placement on 10 June 2021, between the right brachial artery and vein. She experienced graft thrombosis after 12 months and 18 months, both of which were successfully resolved with thrombectomy, in one instance in combination with drug-coated balloon (DCB) angioplasty. The graft remains functional. Case 2: A 76-year-old man received an aXess graft on 11 June 2021, in the left arm. After 6 months, he underwent balloon and DCB angioplasty for graft-vein (G-V) anastomosis stenosis. After 28 months, to resolve multiple pseudoaneurysms, followed by aneurysm resection and AVG reconstruction at month 29, a tunneled catheter was placed to perform dialysis sessions in the meantime. At month 44, graft-venous (G-V) angioplasty with DCB was performed to resolve G-V and axillary vein stenoses diagnosed at month 43. The graft remains in use.

Results

Both patients retained functional dialysis access after four years, despite requiring multiple interventions for thrombosis, stenosis, and pseudoaneurysms.

Conclusions

These cases demonstrate that the aXess graft can maintain functionality over four years with appropriate management, although close surveillance and reinterventions may be required.

Для цитирования: Vitkauskaitė Monika, Rimševičius Laurynas, Girčius Rokas, Cox Martijn A J, Miglinas Marius. Four-Year Outcomes of aXess Arteriovenous Conduit in Hemodialysis Patients: Insights from Two Case Reports of the aXess FIH Study.. Journal of clinical medicine. 2025. DOI: 10.3390/jcm14248768.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.